Literature DB >> 21228308

Imidazoleacetic acid-ribotide induces depression of synaptic responses in hippocampus through activation of imidazoline receptors.

O Bozdagi1, X B Wang, G P Martinelli, G Prell, V L Friedrich, G W Huntley, G R Holstein.   

Abstract

Imidazole-4-acetic acid-ribotide (IAA-RP), an endogenous agonist at imidazoline receptors (I-Rs), is a putative neurotransmitter/regulator in mammalian brain. We studied the effects of IAA-RP on excitatory transmission by performing extracellular and whole cell recordings at Schaffer collateral-CA1 synapses in rat hippocampal slices. Bath-applied IAA-RP induced a concentration-dependent depression of synaptic transmission that, after washout, returned to baseline within 20 min. Maximal decrease occurred with 10 μM IAA-RP, which reduced the slope of field extracellular postsynaptic potentials (fEPSPs) to 51.2 ± 5.7% of baseline at 20 min of exposure. Imidazole-4-acetic acid-riboside (IAA-R; 10 μM), the endogenous dephosphorylated metabolite of IAA-RP, also produced inhibition of fEPSPs. This effect was smaller than that produced by IAA-RP (to 65.9 ± 3.8% of baseline) and occurred after a further 5- to 8-min delay. The frequency, but not the amplitude, of miniature excitatory postsynaptic currents was decreased, and paired-pulse facilitation (PPF) was increased after application of IAA-RP, suggesting a principally presynaptic site of action. Since IAA-RP also has low affinity for α(2)-adrenergic receptors (α(2)-ARs), we tested synaptic depression induced by IAA-RP in the presence of α(2)-ARs, I(1)-R, or I(3)-R antagonists. The α(2)-AR antagonist rauwolscine (100 nM), which blocked the actions of the α(2)-AR agonist clonidine, did not affect either the IAA-RP-induced synaptic depression or the increase in PPF. In contrast, efaroxan (50 μM), a mixed I(1)-R and α(2)-AR antagonist, abolished the synaptic depression induced by IAA-RP and abolished the related increase in PPF. KU-14R, an I(3)-R antagonist, partially attenuated responses to IAA-RP. Taken together, these data support a role for IAA-RP in modulating synaptic transmission in the hippocampus through activation of I-Rs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228308      PMCID: PMC3074409          DOI: 10.1152/jn.00263.2010

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  54 in total

1.  Imidazoline receptor antisera-selected cDNA clone and mRNA distribution.

Authors:  J E Piletz; J C Jones; H Zhu; O Bishara; P Ernsberger
Journal:  Ann N Y Acad Sci       Date:  1999-06-21       Impact factor: 5.691

2.  Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.

Authors:  G A Head
Journal:  Ann N Y Acad Sci       Date:  1999-06-21       Impact factor: 5.691

3.  Organ distribution of rat histidine-pyruvate aminotransferase isoenzymes.

Authors:  T Noguchi; Y Minatogawa; E Okuno; R Kido
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

4.  IRAS, a candidate for I1-imidazoline receptor, mediates inhibitory effect of agmatine on cellular morphine dependence.

Authors:  Ning Wu; Rui-Bin Su; Bo Xu; Xin-Qiang Lu; Yin Liu; Jian-Quan Zheng; John E Piletz; Jin Li; Bo-Yi Qin
Journal:  Biochem Pharmacol       Date:  2005-10-01       Impact factor: 5.858

Review 5.  'Seeing through a glass darkly': casting light on imidazoline 'I' sites.

Authors:  R M Eglen; A L Hudson; D A Kendall; D J Nutt; N G Morgan; V G Wilson; M P Dillon
Journal:  Trends Pharmacol Sci       Date:  1998-09       Impact factor: 14.819

6.  Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance.

Authors:  P Ernsberger; G Feinland; M P Meeley; D J Reis
Journal:  Am J Hypertens       Date:  1990-02       Impact factor: 2.689

7.  Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization.

Authors:  J E Piletz; T R Ivanov; J D Sharp; P Ernsberger; C H Chang; R T Pickard; G Gold; B Roth; H Zhu; J C Jones; J Baldwin; D J Reis
Journal:  DNA Cell Biol       Date:  2000-06       Impact factor: 3.311

8.  Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors.

Authors:  Souhayl Dahmani; Andrea Paris; Virginie Jannier; Lutz Hein; Danielle Rouelle; Jens Scholz; Pierre Gressens; Jean Mantz
Journal:  Anesthesiology       Date:  2008-03       Impact factor: 7.892

9.  S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I(1) receptor ligands.

Authors:  Gerhard J Molderings; Heinz Bönisch; Michael Brüss; Christiana Wolf; Ivar von Kügelgen; Manfred Göthert
Journal:  Neurochem Int       Date:  2007-05-07       Impact factor: 3.921

10.  Presynaptic I1-imidazoline receptors reduce GABAergic synaptic transmission in striatal medium spiny neurons.

Authors:  Mitsuo Tanabe; Yurika Kino; Motoko Honda; Hideki Ono
Journal:  J Neurosci       Date:  2006-02-08       Impact factor: 6.167

View more
  5 in total

1.  Imidazoleacetic acid-ribotide in vestibulo-sympathetic pathway neurons.

Authors:  Gay R Holstein; Victor L Friedrich; Giorgio P Martinelli
Journal:  Exp Brain Res       Date:  2016-07-13       Impact factor: 1.972

2.  Vestibular neurons with direct projections to the solitary nucleus in the rat.

Authors:  Amelia H Gagliuso; Emily K Chapman; Giorgio P Martinelli; Gay R Holstein
Journal:  J Neurophysiol       Date:  2019-06-05       Impact factor: 2.714

3.  Imidazoleacetic acid-ribotide induces depression of synaptic responses in hippocampus through activation of imidazoline receptors.

Authors:  O Bozdagi; X B Wang; G P Martinelli; G Prell; V L Friedrich; G W Huntley; G R Holstein
Journal:  J Neurophysiol       Date:  2011-01-12       Impact factor: 2.714

4.  Levocetirizine-induced Psychiatric Disorders in a Pediatric Patient: A Case Report and a Pharmacovigilance Database Analysis.

Authors:  Carla Carnovale; Simone Russo; Gigliola Biondelli; Marta Gentili; Marco Pozzi; Stefania Antoniazzi; Sonia Radice; Emilio Clementi
Journal:  J Pharmacol Pharmacother       Date:  2017 Apr-Jun

5.  Predicting Vasovagal Responses: A Model-Based and Machine Learning Approach.

Authors:  Theodore Raphan; Sergei B Yakushin
Journal:  Front Neurol       Date:  2021-03-10       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.